Skip to main content
Veterinary Medicines

M+PAC

Authorised
  • Mycoplasma hyopneumoniae, Inactivated

Product identification

Medicine name:
M+PAC
M+PAC
Active substance:
  • Mycoplasma hyopneumoniae, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, Inactivated
    1.47
    relative unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box of 10 bottle of 200 ml
  • Box of 5 bottle of 200 ml
  • Box of 2 bottle of 200 ml
  • Box of 1 bottle of 200 ml
  • Box of 1 bottle of 50 ml
  • Box of 10 bottle of 100 ml
  • Box of 5 bottle of 100 ml
  • Box of 2 bottle of 100 ml
  • Box of 1 bottle of 100 ml
  • Box of 10 bottles of 50 ml
  • Box of 5 bottles of 50 ml
  • Box of 2 bottles of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Burgwedel Biotech GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/236/001
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0140/001/MR
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."